Ellington Management Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-800	Closed	-$300K	–	724
2019 Q4	$300K	Sell	800 -2,100	-72%	-$707K	0.08%	308
2019 Q3	$804K	Buy	2,900 +1,700	+142%	+$503K	0.18%	149
2019 Q2	$376K	Buy	+1,200	New	+$400K	0.07%	301
2018 Q4	–	Sell	-2,000	Closed	-$808K	–	575
2018 Q3	$808K	Sell	2,000 -300	-13%	-$114K	0.23%	126
2018 Q2	$793K	Buy	+2,300	New	+$719K	0.23%	102
2016 Q1	–	Sell	-500	Closed	-$271K	–	663
2015 Q4	$271K	Buy	+500	New	+$271K	0.12%	318
2014 Q1	–	Sell	-800	Closed	-$220K	–	737
2013 Q4	$220K	Sell	800 -1,900	-70%	-$546K	0.08%	417
2013 Q3	$845K	Buy	2,700 +100	+4%	+$26.3K	0.16%	153
2013 Q2	$585K	Buy	+2,600	New	+$605K	0.11%	245